Dr. Chanchal Goswami

Major Cancer Types Treated

• Breast Cancer
• Thoracic Cancers (including Lung Cancer)
• Head and Neck Cancers
• Genitourinary Cancers (Prostate, Bladder, Kidney)
• Gastrointestinal Cancers
• Gynaecological Cancers (Ovarian, Cervical)

• Medical Oncology
• Radiation Oncology
• Immuno-Oncology
• Targeted Therapy

• Immunotherapy
• Targeted Therapy
• Advanced Chemotherapy Protocols
• Intensity-Modulated Radiation Therapy (IMRT)
• Image-Guided Radiation Therapy (IGRT)
• Hormone Therapy

Current Hospital Affiliations:

• Senior Consultant - Medical Oncology, Manipal Hospitals, Dhakuria, Kolkata (Present)

Past Hospital Affiliations:

• Senior Consultant, Medica Superspeciality Hospital, Kolkata
• Senior Consultant, Ruby General Hospital, Kolkata
• Consultant, Calcutta Medical Research Institute (CMRI), Kolkata
• Consultant, Apollo Gleneagles Hospital, Kolkata
• Consultant, B.P. Poddar Hospital and Medical Research, Kolkata
• Consultant, Iris Multispeciality Hospital, Kolkata
• Consultant, CK Birla Hospital, Kolkata
• Registrar, Tata Memorial Hospital, Mumbai

• Principal Investigator in over 50 national and international clinical trials.
• Distinguished author with research articles published in high-impact journals like The Lancet.
• Sought-after speaker at major oncology conferences, including the Affordable Cancer Care in India (ACCI) and the Asian Conference on Tumour Ablation (ACTA).

• One of a few oncologists in India with both advanced medical oncology experience and a postgraduate degree in Radiotherapy.
• Extensive experience and training from the world-renowned MD Anderson Cancer Center, USA.

Recognitions & Honors

• Awarded by the St. Xavier’s College Calcutta Alumni Association for his outstanding contribution to the field of Oncology.

Published Papers in Medical Journals

• Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. - The Lancet (2014)
• Prevalence of BRCA1 and BRCA2 mutations among patients with ovarian, primary peritoneal, and fallopian tube cancer in India: a multicenter cross-sectional study. - JCO Global Oncology (2021)
• A multicenter phase II randomized study of Cremophor-free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline. - Asia-Pacific Journal of Clinical Oncology (2013)
• Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study. - The Lancet Oncology (2012)
• Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India. - Indian Journal of Medical and Paediatric Oncology (2013)

Patient Testimonials

• "Dr. Chanchal Goswami is a true authority in oncology. He treated my father's lung cancer with a combination of immunotherapy and precision radiation. His ability to explain complex treatments and his reassuring demeanour gave our family immense confidence. He is without a doubt the top oncologist in Kolkata." - S. Banerjee
• "After being diagnosed with breast cancer, I was looking for the best possible care. Dr. Goswami’s international training and vast experience were evident from our first meeting. He created a comprehensive treatment plan for me, and his team provided compassionate care throughout. I am now cancer-free and eternally grateful." - A. Dasgupta
• "My experience with Dr. Goswami was exceptional. He was the principal investigator for a clinical trial that I enrolled in for my condition. His dedication to research and bringing new treatments to patients in India is truly commendable. I felt I was in the most capable and knowledgeable hands." - R. Sharma

• Patient-Centred Care: Dr. Goswami is deeply committed to providing personalised care. Being fluent in English, Bengali, and Hindi, he connects with patients from diverse backgrounds, ensuring they understand their diagnosis and treatment options completely. He champions a supportive and empathetic environment for patients on their journey to recovery.
• Technology & Innovation: With a foundation in research and international training, Dr. Goswami is a leader in adopting cutting-edge treatments. His role as a Principal Investigator in over 50 clinical trials showcases his dedication to advancing medical science. He expertly combines chemotherapy, immunotherapy, targeted drugs, and advanced radiotherapy techniques to offer the most effective, evidence-based care.

For consultation fees, you can connect with the Cancer Rounds team.

The cost of cancer treatment varies based on the diagnosis, the specific treatment modalities used (e.g., radiotherapy, immunotherapy), and the duration of care. The table below provides an estimated cost for treatments offered by Dr. Goswami.

Note: These costs are approximate. The final treatment cost will depend on the patient's individual medical needs, specific drugs or technology used, and hospital stay. For a precise cost estimate, please connect with the Cancer Rounds team.

• Language Support: The Cancer Rounds team provides dedicated language interpreters to ensure seamless and clear communication for international patients during their consultation and treatment journey.
• Visa & Travel Assistance: We offer comprehensive support for medical visa applications, travel planning, airport transfers, and booking comfortable accommodation near the hospital.
• Pre-treatment Virtual Consultations: Dr. Goswami is available for pre-travel online video consultations. This allows international patients to share their medical history, receive a second opinion, and understand the proposed treatment plan before coming to India.